| ||
Name: 2'-bromo-4'-epidaunorubicin | ||
Formula: C27 H28 Br N O10 | ||
Weight: 606.416 | ||
SMILES: "COc1cccc2C(=O)c3c(O)c4C[C](O)(C[CH](O[CH]5O[CH](C)[CH](O)[CH](N)[CH]5Br)c4c(O)c3C(=O)c12)C(C)=O" | ||
Spacial conformation based on PDB
288d. Also present in other 5 PDB entries. |
RESIDUE DM8 67 CONECT C1 3 C2 C15 H1 CONECT C2 3 C1 C3 H2 CONECT C3 3 C2 C4 H3 CONECT C4 3 C3 C16 O4 CONECT C5 3 C16 C17 O5 CONECT C6 3 C17 C20 O6 CONECT C7 4 C8 C20 O7 H7 CONECT C8 4 C7 C9 H81 H82 CONECT C9 4 C8 C10 C13 O9 CONECT C10 4 C9 C19 H101 H102 CONECT C11 3 C18 C19 O11 CONECT C12 3 C15 C18 O12 CONECT C13 3 C9 C14 O13 CONECT C14 4 C13 H141 H142 H143 CONECT C15 3 C1 C12 C16 CONECT C16 3 C4 C5 C15 CONECT C17 3 C5 C6 C18 CONECT C18 3 C11 C12 C17 CONECT C19 3 C10 C11 C20 CONECT C20 3 C6 C7 C19 CONECT C21 4 O4 H211 H212 H213 CONECT O4 2 C4 C21 CONECT O5 1 C5 CONECT O6 2 C6 H6 CONECT O7 2 C7 C1' CONECT O9 2 C9 H9 CONECT O11 2 C11 H11 CONECT O12 1 C12 CONECT O13 1 C13 CONECT C1' 4 O7 C2' O5' H1' CONECT C2' 4 C1' C3' BR H2' CONECT C3' 4 C2' C4' N3' H3' CONECT C4' 4 C3' C5' O4' H4' CONECT C5' 4 C4' C6' O5' H5' CONECT C6' 4 C5' H6'1 H6'2 H6'3 CONECT O5' 2 C1' C5' CONECT O4' 2 C4' HO4' CONECT N3' 3 C3' HN'1 HN'2 CONECT BR 1 C2' CONECT H1 1 C1 CONECT H2 1 C2 CONECT H3 1 C3 CONECT H7 1 C7 CONECT H81 1 C8 CONECT H82 1 C8 CONECT H101 1 C10 CONECT H102 1 C10 CONECT H141 1 C14 CONECT H142 1 C14 CONECT H143 1 C14 CONECT H211 1 C21 CONECT H212 1 C21 CONECT H213 1 C21 CONECT H6 1 O6 CONECT H9 1 O9 CONECT H11 1 O11 CONECT H1' 1 C1' CONECT H2' 1 C2' CONECT H3' 1 C3' CONECT H4' 1 C4' CONECT H5' 1 C5' CONECT H6'1 1 C6' CONECT H6'2 1 C6' CONECT H6'3 1 C6' CONECT HO4' 1 O4' CONECT HN'1 1 N3' CONECT HN'2 1 N3' END HET DM8 67 HETSYN DM8 WP401; DAUNOMYCIN DERIVATIVE; DAUNORUBICIN DERIVATIVE HETNAM DM8 2'-BROMO-4'-EPIDAUNORUBICIN FORMUL DM8 C27 H28 Br1 N1 O10
This OCA
MONOMER page uses Jmol, developed by the Jmol Development Team (color reference)
|